Preveceutical Medical Inc (PREV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 10 | 10 | 10 | 5 | 75 |
| Income taxes - deferred | N/A | N/A | 0 | -20 | -6 |
| Accounts receivable | -22 | 13 | -2 | 36 | 6 |
| Other Working Capital | 343 | 527 | 495 | 593 | 698 |
| Other Operating Activity | -758 | -847 | -725 | -1,040 | -709 |
| Operating Cash Flow | $-427 | $-297 | $-223 | $-426 | $65 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | 0 | 1 | 3 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -55 | -3 |
| Investing Cash Flow | $-2 | $0 | $1 | $-53 | $-3 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 248 | 94 | 218 | 47 | N/A |
| Debt Issued | N/A | 199 | 0 | 90 | 227 |
| Debt Repayment | N/A | N/A | N/A | 0 | -45 |
| Common Stock Issued | 95 | N/A | N/A | 0 | 0 |
| Other Financing Activity | 145 | 0 | -6 | 0 | 3 |
| Financing Cash Flow | $488 | $294 | $212 | $137 | $184 |
| Exchange Rate Effect | -1 | -1 | 0 | 202 | -118 |
| Beginning Cash Position | 1 | 6 | 16 | 156 | 28 |
| End Cash Position | 59 | 1 | 6 | 16 | 156 |
| Net Cash Flow | $59 | $-3 | $-10 | $-342 | $246 |
| Free Cash Flow | |||||
| Operating Cash Flow | -427 | -297 | -223 | -426 | 65 |
| Capital Expenditure | -2 | N/A | N/A | -55 | -3 |
| Free Cash Flow | -428 | -297 | -223 | -482 | 62 |